Greenway Medical Technologies, Inc. today announced the deployment of its fully-integrated electronic health record (EHR), practice management and interoperability solution, PrimeSuite®,into Palm Beach County, Florida's Bethesda Healthcare System (BHS) and its flagship hospital, Bethesda Memorial Hospital. BHS operates the 401-bed hospital as well as specialty practices that include family practice, internal medicine, cardiovascular surgery, neurology and orthopedics.

As part of its initiative to develop the intellectual property for new, unique health and safety products available for global distribution, American Scientific Resources, Inc. (the "Company" or "ASR") today announced the launch of a new line of affordable, revolutionary, 5-in-1 non-contact thermometers specifically designed to meet the needs of consumers and healthcare workers around the globe.

By utilizing the latest technological innovations, in managements' opinion, ASR was able to make this new device affordable for the consumer, as accurate as most trusted thermometers, and easy-to-use for a touch-less, instant temperature reading.

Suits were commenced Dec. 23, 2009 in North Carolina for four users who allege kidney damage due to the use of OsmoPrep, a prescription drug used to cleanse the intestines in preparation for a colonoscopy. (Holshouser et al v. Salix Pharmaceuticals, Ltd. and Salix Pharmaceuticals. Inc.)

The actions are against two Morrisville, N.C., pharmaceutical companies, Salix Pharmaceuticals, Ltd., and Salix Pharmaceuticals, Inc. . The company, which specializes in marketing gastrointestinal drugs, began selling OsmoPrep in 2006. It had over $30 million in sales in 2008.

A new and innovative mass spectrometry-based detection service developed to help researchers better understand protein interactions and their contributions to cell signaling and metabolism is now available from Dualsystems Biotech AG. Designed to identify the composition of protein complexes directly from mammalian cells, CaptiVate™ Interactor Analysis is a comprehensive service that includes the generation of a stably transfected cell line expressing the protein of interest,

Ventana Biotech Inc. ("Ventana") (PINK SHEETS: VNTA), a biotechnology company developing medicated chewing gums, today announced that it has signed a deal with GTMC, a Korean distribution company, for the distribution of Ventana's appetite suppressant and stress reducing chewing gums.

The deal will see Ventana's products distributed initially to South Korea and, later, to Japan through GTMC's network of manufacturing and distribution partners.

Omega's new standalone datalogger features a high contrast LCD that can show a variety of temperature and humidity information. With this unit the user can cycle between current readings, along with maximum and minimum stored values for temperature and humidity. It features immediate, delayed and push-to-start logging.

Choose an easily integrated, low cost, high performance, 2-phase or 4-phase, linear stepper motor from H2W Technologies to improve the performance of an existing motion control system or create a new high speed, high accuracy system. These, compact, industry standard, “12 lb. Linear Steppers” (53 N continuous Force, 16 lbs, 71 N peak force) travel at 80 in/sec. [2 m/sec.], with 1 micron [0.00004 in.] resolution, and can operate in any axis.

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), Gurgaon, India, announced an agreement with Validus Pharmaceuticals LLC (Validus) to market and distribute an authorized generic version of Rocaltrol® (calcitriol) in both softgel capsules and an oral liquid formulation. Overall market sales for calcitriol softgel capsules and oral liquid were $70 million (IMS - MAT: June 2009).

Mylan Inc. (Nasdaq: MYL - News) today announced that its subsidiary Mylan Pharmaceuticals Inc. has begun to market 1% Clindamycin and 5% Benzoyl Peroxide Gel based on an agreement with licensing partner Dow Pharmaceutical Sciences, a subsidiary of Valeant Pharmaceuticals International. The preparation is the first generic version of Sanofi Aventis' BenzaClin® to be approved by the U.S. Food and Drug Administration (FDA).

Shimadzu Scientific Instruments introduces SeqLab(tm) de-novo sequencing software for use with the AXIMA(tm) line of MALDI mass spectrometers. The software uses a high-power de-novo sequencing engine, MS/MS and possible related MS/MS/MS data to help decipher peptide sequences.